BIOMAT Database Logo BIOMAT Database Logo

Neuropharmacologic analysis of AHR-2277 a new psychotherapeutic agent. 1971

D N Johnson, and W H Funderburk, and J W Ward

UI MeSH Term Description Entries
D008297 Male Males
D010880 Piperidines A family of hexahydropyridines.
D002090 Butyrophenones Compounds containing phenyl-1-butanone.
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D003441 Crowding An excessive number of individuals, human or animal, in relation to available space.
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005071 Evoked Potentials Electrical responses recorded from nerve, muscle, SENSORY RECEPTOR, or area of the CENTRAL NERVOUS SYSTEM following stimulation. They range from less than a microvolt to several microvolts. The evoked potential can be auditory (EVOKED POTENTIALS, AUDITORY), somatosensory (EVOKED POTENTIALS, SOMATOSENSORY), visual (EVOKED POTENTIALS, VISUAL), or motor (EVOKED POTENTIALS, MOTOR), or other modalities that have been reported. Event Related Potential,Event-Related Potentials,Evoked Potential,N100 Evoked Potential,P50 Evoked Potential,N1 Wave,N100 Evoked Potentials,N2 Wave,N200 Evoked Potentials,N3 Wave,N300 Evoked Potentials,N4 Wave,N400 Evoked Potentials,P2 Wave,P200 Evoked Potentials,P50 Evoked Potentials,P50 Wave,P600 Evoked Potentials,Potentials, Event-Related,Event Related Potentials,Event-Related Potential,Evoked Potential, N100,Evoked Potential, N200,Evoked Potential, N300,Evoked Potential, N400,Evoked Potential, P200,Evoked Potential, P50,Evoked Potential, P600,Evoked Potentials, N100,Evoked Potentials, N200,Evoked Potentials, N300,Evoked Potentials, N400,Evoked Potentials, P200,Evoked Potentials, P50,Evoked Potentials, P600,N1 Waves,N2 Waves,N200 Evoked Potential,N3 Waves,N300 Evoked Potential,N4 Waves,N400 Evoked Potential,P2 Waves,P200 Evoked Potential,P50 Waves,P600 Evoked Potential,Potential, Event Related,Potential, Event-Related,Potential, Evoked,Potentials, Event Related,Potentials, Evoked,Potentials, N400 Evoked,Related Potential, Event,Related Potentials, Event,Wave, N1,Wave, N2,Wave, N3,Wave, N4,Wave, P2,Wave, P50,Waves, N1,Waves, N2,Waves, N3,Waves, N4,Waves, P2,Waves, P50
D005260 Female Females

Related Publications

D N Johnson, and W H Funderburk, and J W Ward
[AHR-2277: a new major neuroleptic with minimal neurological side-effects].
January 1973, Annales medico-psychologiques,
D N Johnson, and W H Funderburk, and J W Ward
Assessment of antipsychotic activity of a butyrophenone analogue, lenperone (AHR 2277).
August 1974, Current therapeutic research, clinical and experimental,
D N Johnson, and W H Funderburk, and J W Ward
Pilot open-label study of lenperone (AHR 2277), a butyrophenone, in anxiety.
March 1976, Current therapeutic research, clinical and experimental,
D N Johnson, and W H Funderburk, and J W Ward
Toxicology of nialamide, a new psychotherapeutic agent.
September 1959, Toxicology and applied pharmacology,
D N Johnson, and W H Funderburk, and J W Ward
An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
May 1974, Current therapeutic research, clinical and experimental,
D N Johnson, and W H Funderburk, and J W Ward
[Clinical experience with a new psychotherapeutic agent: methyldiazepinone].
March 1963, La Clinica terapeutica,
D N Johnson, and W H Funderburk, and J W Ward
Clinical experience with chlorprothixene, a new psychotherapeutic agent.
August 1962, Diseases of the nervous system,
D N Johnson, and W H Funderburk, and J W Ward
Antipsychotic effects, side effects and effective dosis of the butyrophenone lenperone (AHR 2277).
January 1977, International pharmacopsychiatry,
D N Johnson, and W H Funderburk, and J W Ward
Neuropharmacologic evaluation of oxilapine, a potent psychoactive agent.
March 1969, The Journal of pharmacology and experimental therapeutics,
D N Johnson, and W H Funderburk, and J W Ward
The clinical evaluation of dxepin--a new psychotherapeutic agent.
January 1969, Psychosomatics,
Copied contents to your clipboard!